BioProcess International

Paradigm Shift in Chemistry, Manufacturing, and Controls: The FDA’s Finalized Flexible Framework for Cell and Gene Therapy Approvals

The FDA’s May 2026 guidance on cell and gene therapies provides for CMC flexibilities while insisting on quality and ...